VeriMom¿Es bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer seguro durante el embarazo?
No harmonised CLP reproductive classification listed in ECHA Annex VI and no SCCS or CIR safety assessment identifying reproductive hazard for this polymer. Peer‑reviewed or regulatory literature does not report teratogenicity or reproductive toxicity for the polymer itself; concerns would be about residual monomers such as HEMA or isocyanates, but no data show reproductive effects from the finished polymer as used in cosmetics (sources consulted: ECHA Annex VI, SCCS/CIR absence, PubMed absence).
Related ingredients
Frequently asked questions
- ¿Es bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer seguro durante el embarazo?
- No harmonised CLP reproductive classification listed in ECHA Annex VI and no SCCS or CIR safety assessment identifying reproductive hazard for this polymer. Peer‑reviewed or regulatory literature does not report teratogenicity or reproductive toxicity for the polymer itself; concerns would be about residual monomers such as HEMA or isocyanates, but no data show reproductive effects from the finished polymer as used in cosmetics (sources consulted: ECHA Annex VI, SCCS/CIR absence, PubMed absence).
- ¿Es bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer seguro durante la lactancia?
- As for pregnancy: the polymer has high molecular weight and is expected to have negligible systemic absorption when applied topically; no evidence of transfer via breastmilk for the polymer itself reported in regulatory or peer‑reviewed sources. Potential issue would be unreacted monomers, but no regulatory assessments identify breastfeeding risk for the finished polymer (sources: CIR/SCCS absence, PubMed absence, CosIng/ECHA listings if present without classification).
- ¿Es bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer seguro para la piel del bebé?
- High molecular weight polymeric material is expected to have negligible dermal absorption in adults and in infants; no data indicate infant‑specific reproductive mechanism or developmental toxicity from the polymer. Because the polymer is large and crosslinked, dermal penetration is unlikely; therefore exposure for 0–3 y is considered negligible. Note: if residual low‑MW monomers/oligomers (HEMA, IPDI fragments) are present at meaningful levels, infant exposure could be higher—no data on residual monomer content were found (sources: ECHA, CosIng, PubMed).
- ¿Cómo puntúa VeriMom a bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer?
- VeriMom puntúa bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer en el embarazo?
- Consulta nuestra lista de alternativas seguras a bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.